Key facts
- It has raised $3.8M across 3 recorded rounds; the latest was Seed Round ($350K) in Dec 2024.
- Notable investors include Innovation Fund America, Serial Stage Venture Partners.
- Aatru Medical has filed 9 Form Ds with the SEC since 2017, most recently Sep 2025 ($75K sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Aatru Medical
Funding rounds
3 roundsAbout Aatru Medical
Developer of a medical device company intended to treat wounds and damaged skin. The company offers a portable, wearable, completely self-contained, negative pressure bandage that assists in drawing wound edges together, increasing circulation in the wound bed, reducing wound exudate, and promoting granulation of tissue formation, enabling healthcare professionals to provide post-surgical incision and tissue treatment in the cosmetic and aesthetic markets.
- Sector
- Healthcare
- HQ
- Cleveland, OH, United States
- Founded
- 2015
- Employees
- 6
- Website
- aatru.com/
- Ownership
- Privately Held (backing)
Aatru Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aatru Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aatru Medical in its N-PORT filings yet. We sweep new filings monthly.